Scientific Sessions 2024  /  Cardiometabolic Factors: Global Burden and Innovative Solutions  /  A New Era of Innovative Antihypertensive Treatment
Logo

American Heart Association

  15
  0

Final ID:

A New Era of Innovative Antihypertensive Treatment

  • Wang, Jiguang  ( , Shanghai , China )
    • Author Disclosures:
    Jiguang Wang: DO have relevant financial relationships ; Speaker:Novartis:Active (exists now) ; Speaker:Viatris:Active (exists now) ; Speaker:Servier:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cardiometabolic Factors: Global Burden and Innovative Solutions

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Global Roundtable

More abstracts on this topic:
Priorities for Improving Cardiometabolic Health in the Americas

Piskorz Daniel

Cardiorenal syndrome - The cardiologist perspective

Skalsky Keren

More abstracts from these authors:
Efficacy and safety of aprocitentan in patients with resistant hypertension and elevated NT-proBNP

Weber Michael, Bakris George, Gimona Alberto, Narkiewicz Krzysztof, Schlaich Markus, Sassi-sayadi Mouna, Wang Jiguang, Flack John

Impact of arterial stiffness on the blood pressure lowering effect of the dual endothelin antagonist aprocitentan in patients with resistant hypertension

Schlaich Markus, Bakris George, Flack John, Danaietash Parisa, Sassi-sayadi Mouna, Narkiewicz Krzysztof, Wang Jiguang, Weber Michael

You have to be authorized to contact abstract author. Please, Login
Not Available